ETIZOLAM suppliers
ETIZOLAM
- CAS:
- 40054-69-1
- MF:
- C17H15ClN4S
- MW:
- 342.85
Properties
- Melting point:
- 147-148℃
- Boiling point:
- 264.5°C (rough estimate)
- Density
- 1.43
- refractive index
- 1.6100 (estimate)
- Flash point:
- 9°C
- storage temp.
- -20°C
- solubility
- DMF: 5 mg/ml; DMSO: 5 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml
- form
- A neat solid
- pka
- 2.37±0.40(Predicted)
Safety Information
- Symbol(GHS)
GHS02, GHS06, GHS08
- Signal word
- Danger
- Hazard statements
- H225-H301+H311+H331-H370
- Precautionary statements
- P210-P260-P280-P301+P310-P311
- Hazard Codes
- F,T
- Risk Statements
- 11-23/24/25-39/23/24/25
- Safety Statements
- 7-16-36/37-45
- RIDADR
- UN1230 - class 3 - PG 2 - Methanol, solution
- WGK Germany
- 1
- Toxicity
- LD50 in male, female rats, male, female mice (mg/kg): 3619, 3509, 4358, 4258 orally; 865, 825, 830, 783 i.p.; >5000 s.c. (Tsumagari)
Use
https://www.drugbank.ca/drugs/DB09166 https://en.wikipedia.org/wiki/Etizolam Casacchia, Massimo, F. Bolino, and U. Ecari. Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo.Current Medical Research Opinion 12.4(2008):215-223. Savoldi, F, G. Somenzini, and U. Ecari. Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study.Current Medical Research Opinion 12.3(1990):185. Hirashima, Y, et al. Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma--evaluation by computed tomography. Neurologia medico-chirurgica 42.2(2002):53-55.
According to relevant laws, regulations, policies and the provisions of this website, this website does not display the product information!
The source is "精神麻醉类药品". If the information is inaccurate, please contact the platform to modify it.
contact information：info@chemicalbook.com 400-158-660